(Q83938445)
Statements
Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo (English)
Yan Li
Sheng Zhao
Wei Zhang
Peng Zhao
Bing He
Na Wu